MMXIX-nCoV S-RBD Neutralizing Antibody Test Kit (colloidale aurum modum)
Introductio
Nunc omnes vaccini candidati in evolutione clinica MMXIX-nCoV administrantur ab injectione intramusculari.Vaccinatio intramuscularis vel intradermal ad validam inductionem serum Igg
Plus quam 180 candidati vaccini, pluribus diversis suggestis innixi nunc in evolutione contra 2019-nCoV sunt.
S interdum maior est scopo corrumpendi elementorum;
Multi ex his elementis corrumpendis RBD of S interdum oppugnant.
Quomodo iudicare efficientiam 2019-nCoV vaccine?--- Neutralizing Antibody Test Kit
Commodum
Pre probatio vaccini
Candidati ante vaccinationem possunt deprehendere ad anticorpus RBD neutralisandum determinare utrum vaccinatio necessaria sit;
Most vaccina teguntur
Deprehendere potest corrumpendi elementorum quae a plerisque vaccinis in foro producta sunt;
Ieiunium et opportunum
Operatio simplex est, nullo instrumento detecto opus est, eventus intra 15 minutas obtineri potest.
Lepidium sativum munus
Distinguendum est neutralizans anticorpus 2019-nCoV productum ab 2019-nCoV vaccinum vel anticorpus ab 2019-nCoV infectio quaedam vaccina producta, ut vector Viralis (Non-replicating) vaccinum, RNA basi vaccinum et interdum subunitum vaccinum ;
Totum sanguinem test
Totus sanguis expertus operationem commodiorem facit;
Locum applicationis
Pre vaccination
Utrum novis coronavirus infecti fuerint et an vaccinated adhuc opus sit;
Vaccination tempus
Determinare an efficax novum anticorpus neutralising producatur;
Nuper scaena inoculationis
Iuxta epidemiam aream 2019-nCoV, suadet deprehendere exsistentiam MMXIX-nCoV corrumpere anticorpum regulariter singulis tribus mensibus.
Components
Components | Pelagus Rebus | Quantitas loading (specification) | ||
1 T/Kit | 20 T/Kit | 50 T/Kit | ||
Test card | Testi habena continens colloidal aurum intitulatum anti-humanum IgG anticorpus, aurum colloidale intitulatum anti-galli IgY antibody, 2019-nCoV S-RBD dapibus recombinantibus, Pullus IgY antibody | 1 pc* | 20 pcs | 50 at pede |
Sample diluent | 0.01M Phosphas solutionis quiddam, 0.5% Twen-20 | 0.5mL | 5mL | 10mL |
Euismod
Hecin tenui | Serum virus neutralization clinicae test | Totalis | |
Positivum | Negative | ||
Positivum | Positivum | 84 | 9 |
Negative | Negative | 8 | 198 |
Totalis | Totalis | 92 | 207 |
Fusce sensus | Fusce sensus | 84/92 91.30% (95%CI: 83.58%~96.17%) | |
Fusce specificity | Fusce specificity | 198/207 95.65% (95%CI: 91.91%~97.99%) | |
Sagacitas | Sagacitas | 282/299 94.31% (95%CI: 91.05%~96.65%) |
Hecin gerens euismod contra methodum comparatorem in speciminibus seri/plasma.
Hecin tenui | Serum virus neutralization clinicae test | Totalis | |
Positivum | Negative | ||
Positivum | 84 | 8 | 92 |
Negative | 8 | 199 | 207 |
Totalis | 92 | 207 | 299 |
Fusce sensus | 84/92 91.30% (95%CI: 83.58%~96.17%) | ||
Fusce specificity | 199/207 96.14% (95%CI: 92.53%~98.32%) | ||
Sagacitas | 283/299 94.65% (95%CI: 91.46%~96.91%) |
Hecin gerens euismod contra Comparatorem Methodi speciminum integrorum sanguinis.
Test De modo procedendi
Registration Certificatorium
JT08- 1T
JT08- 5T
JT08- 50T